Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Pharmacoeconomics|February 25, 2023
Economic Analyses of Obsessive-Compulsive Disorder Interventions: A Systematic ReviewEmily R Strouphauer, Olivia J Morris, Keaton J Soileau, et al.
American Journal on Intellectual and Developmental Disabilities|April 27, 2025
Effects of Stepped Cognitive Behavioral Therapy on Child Depressive and Externalizing Symptoms in Autistic Children With AnxietyCatherine E Rast, Andrew G Guzick, Keaton J Soileau, et al.
Neurology and Therapy|April 20, 2022
Comparative Effectiveness of Carbidopa-Levodopa Enteral Suspension and Deep Brain Stimulation on Parkinson's Disease-Related Pill Burden Reduction in Advanced Parkinson's Disease: A Retrospective Real-World Cohort StudyMichael J Soileau, Fernando Pagan, Alfonso Fasano, et al.
Movement Disorders Clinical Practice|July 30, 2025
Efficacy and Safety of Foslevodopa/Foscarbidopa Monotherapy in Patients with Parkinson's DiseaseJason Aldred, Manon Bouchard, Juan Carlos Martínez-Castrillo, et al.
Neurology and Therapy|January 18, 2023
Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson's DiseaseMichael J Soileau, Fernando L Pagan, Alfonso Fasano, et al.
Neurology and Therapy|October 4, 2025
Improvement in Motor Consistency and Stability with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Post Hoc Analysis of Two Phase 3 Clinical TrialsRajesh Pahwa, Jason Aldred, Michael J Soileau, et al.
The Lancet. Neurology|November 19, 2022
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialMichael J Soileau, Jason Aldred, Kumar Budur, et al.
Neurology and Therapy|January 11, 2022
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson's Disease: Real-World Evidence From G7 CountriesAngelo Antonini, Rajesh Pahwa, Per Odin, et al.
BMC Neurology|January 25, 2022
Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countriesIrene A Malaty, Pablo Martinez-Martin, K Ray Chaudhuri, et al.
NPJ Digital Medicine|January 14, 2026
Real-world multicenter assessment of sustained clinical outcomes after digital deep brain stimulationAlireza Gharabaghi, Sergiu Groppa, Elena Casas, et al.
Pageof 5